Update in global trends and aetiology of hepatocellular carcinoma

被引:255
|
作者
Rawla, Prashanth [1 ]
Sunkara, Tagore [2 ]
Muralidharan, Pradhyumna [3 ]
Raj, Jeffrey Pradeep [3 ]
机构
[1] Sovah Hlth, Dept Internal Med, 320 Hosp Dr, Martinsville, VA 24112 USA
[2] Mt Sinai Hosp, Brooklyn Hosp Ctr, Div Gastroenterol & Hepatol, Clin Affiliate, New York, NY 10029 USA
[3] St Johns Med Coll, Dept Pharmacol, Bengaluru, India
来源
关键词
epidemiology; aetiology; hepatocellular carcinoma; HCC; risk factors; hepatitis C; HBV; incidence; prevalance; mortality;
D O I
10.5114/wo.2018.78941
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver responsible for an increasing number of cancer-related deaths, especially in developing economies of Asia and Africa. A plethora of risk factors have been described in the literature. Some of the important ones include chronic viral hepatitis, liver cirrhosis, environmental toxins such as aflatoxin, non-alcoholic fatty liver disease, lifestyle factors like alcohol consumption, smoking, and dietary factors, metabolic diseases like diabetes mellitus and obesity, and genetic and hereditary disorders. The development of HCC is complex involving sustained inflammatory damage leading to hepatocyte necrosis, regeneration, and fibrotic deposition. It also poses multiple challenges in diagnosis and treatment despite advances in diagnostic, surgical, and other therapeutic advancements. This is a narrative review of findings of multiple studies that were retrieved from electronic databases like PubMed, MEDLINE, Embase, Google Scholar, Scopus, and Cochrane. We summarise the current knowledge regarding the epidemiology and various risk factors for the development of HCC with a brief note on various prevention strategies.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 50 条
  • [41] An update on the role of complement in hepatocellular carcinoma
    Xiao, Zhijie
    Yeung, Charlie Lot Sum
    Yam, Judy Wai Ping
    Mao, Xiaowen
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] ASCO update: hepatocellular and cholangiocellular carcinoma
    Angela Djanani
    [J]. memo - Magazine of European Medical Oncology, 2022, 15 : 259 - 263
  • [43] Hepatocellular Carcinoma in 2021: An Exhaustive Update
    Philips, Cyriac A.
    Rajesh, Sasidharan
    Nair, Dinu C.
    Ahamed, Rizwan
    Abduljaleel, Jinsha K.
    Augustine, Philip
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [44] Genetic alterations in hepatocellular carcinoma: An update
    Zhao-Shan Niu
    Xiao-Jun Niu
    Wen-Hong Wang
    [J]. World Journal of Gastroenterology, 2016, 22 (41) : 9069 - 9095
  • [45] Diagnosis and treatment of hepatocellular carcinoma: An update
    Tejeda-Maldonado, Javier
    Garcia-Juarez, Ignacio
    Aguirre-Valadez, Jonathan
    Gonzalez-Aguirre, Adrian
    Vilatoba-Chapa, Mario
    Armengol-Alonso, Alejandra
    Escobar-Penagos, Francisco
    Torre, Aldo
    Francisco Sanchez-Avila, Juan
    Luis Carrillo-Perez, Diego
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (03) : 362 - 376
  • [46] Update on hepatocellular carcinoma: Pathologists' review
    El Jabbour, Tony
    Lagana, Stephen M.
    Lee, Hwajeong
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (14) : 1653 - 1665
  • [47] Genetic alterations in hepatocellular carcinoma: An update
    Niu, Zhao-Shan
    Niu, Xiao-Jun
    Wang, Wen-Hong
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (41) : 9069 - 9095
  • [48] ASCO update: hepatocellular and cholangiocellular carcinoma
    Djanani, Angela
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (04) : 259 - 263
  • [49] An Update on the Pathogenesis and Pathology of Hepatocellular Carcinoma
    Satir, Ali Abdel
    [J]. BAHRAIN MEDICAL BULLETIN, 2007, 29 (02)
  • [50] Update on Embolization Therapies for Hepatocellular Carcinoma
    Sirish Kishore
    Tamir Friedman
    David C. Madoff
    [J]. Current Oncology Reports, 2017, 19